General information

The limited liability company “BioJet” was established in 2021 and is part of the Russian pharmaceutical holding “PharmEco”.

The production site of LLC “BioJet” with an area of 4.142 sq.m. is located on the territory of the Special Economic Zone “Technopolis Moscow”.

In 2022, the Moscow Government awarded the company the status of a resident of the Technopolis Moscow SEZ with the allocation of regional tax benefits.

The main activity of the enterprise is the production of modern biotechnological medicines.


Kornienko Andrey Alekseevich

Education: Moscow State University of Food Industry – (specialty engineer-technologist) and I.M. Sechenov First Moscow State Medical University (industrial pharmacy).

He has been working in the pharmaceutical industry since 1999.

He worked in pharmaceutical companies FSUE Moskhimpharmparaty named after N.A.Semashko, Pharmaceutical company Sotex, Petrovax, Takeda, Abbott/Veropharm.

He is married and has two children.


Pharmacovigilance is a type of activity for monitoring the effectiveness and safety of medicines aimed at identifying, evaluating and preventing adverse events when taking medicines.

Business ethics

The company adheres to high standards of business ethics, transparency and legality. We have consolidated our principle of rejection of corruption and violations in the field of business ethics in any form and manifestations (the principle of “zero tolerance”) both in our operational activities and in the implementation of strategic projects, in interaction with business partners, contractors, employees, officials and other persons.